843 related articles for article (PubMed ID: 28608560)
1. Endocannabinoid system in neurodegenerative disorders.
Basavarajappa BS; Shivakumar M; Joshi V; Subbanna S
J Neurochem; 2017 Sep; 142(5):624-648. PubMed ID: 28608560
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoids and neurodegenerative diseases.
Micale V; Mazzola C; Drago F
Pharmacol Res; 2007 Nov; 56(5):382-92. PubMed ID: 17950616
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states.
Karanian DA; Bahr BA
Curr Mol Med; 2006 Sep; 6(6):677-84. PubMed ID: 17022737
[TBL] [Abstract][Full Text] [Related]
4. The role of the endocannabinoid system in Alzheimer's disease: facts and hypotheses.
Bisogno T; Di Marzo V
Curr Pharm Des; 2008; 14(23):2299-3305. PubMed ID: 18781980
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid system in neuropathological states.
Orgado JM; Fernández-Ruiz J; Romero J
Int Rev Psychiatry; 2009 Apr; 21(2):172-80. PubMed ID: 19367511
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders.
Bisogno T; Di Marzo V
CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):564-73. PubMed ID: 20632970
[TBL] [Abstract][Full Text] [Related]
8. The Endocannabinoid System and its Modulation by Phytocannabinoids.
Di Marzo V; Piscitelli F
Neurotherapeutics; 2015 Oct; 12(4):692-8. PubMed ID: 26271952
[TBL] [Abstract][Full Text] [Related]
9. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
Ligresti A; Petrosino S; Di Marzo V
Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
[TBL] [Abstract][Full Text] [Related]
10. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.
Basavarajappa BS; Nixon RA; Arancio O
Mini Rev Med Chem; 2009 Apr; 9(4):448-62. PubMed ID: 19356123
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid system as a target for the treatment of neurodegenerative disease.
Scotter EL; Abood ME; Glass M
Br J Pharmacol; 2010 Jun; 160(3):480-98. PubMed ID: 20590559
[TBL] [Abstract][Full Text] [Related]
13. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
[TBL] [Abstract][Full Text] [Related]
14. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
Fride E
Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
Aymerich MS; Aso E; Abellanas MA; Tolon RM; Ramos JA; Ferrer I; Romero J; Fernández-Ruiz J
Biochem Pharmacol; 2018 Nov; 157():67-84. PubMed ID: 30121249
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid overactivity and intestinal inflammation.
Di Marzo V; Izzo AA
Gut; 2006 Oct; 55(10):1373-6. PubMed ID: 16966693
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptors and their role in neuroprotection.
van der Stelt M; Di Marzo V
Neuromolecular Med; 2005; 7(1-2):37-50. PubMed ID: 16052037
[TBL] [Abstract][Full Text] [Related]
18. An enquiry to the role of CB1 receptors in neurodegeneration.
Fernández-Moncada I; Eraso-Pichot A; Dalla Tor T; Fortunato-Marsol B; Marsicano G
Neurobiol Dis; 2023 Aug; 184():106235. PubMed ID: 37481040
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoids as Therapeutic Targets.
Prospéro-García O; Ruiz Contreras AE; Ortega Gómez A; Herrera-Solís A; Méndez-Díaz M;
Arch Med Res; 2019 Nov; 50(8):518-526. PubMed ID: 32028095
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoid mechanisms of pain modulation.
Hohmann AG; Suplita RL
AAPS J; 2006 Nov; 8(4):E693-708. PubMed ID: 17233533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]